Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Nephrology
|
January 1, 1990
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees
F Scolari, P Scaini, S Savoldi, et al.
The American Journal of Pathology
|
January 1, 1992
Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index
G R Merlo, T Venesio, A Bernardi, et al.
Gene Geography : a Computerized Bulletin on Human Gene Frequencies
|
April 1, 1991
HLA class II gene frequencies in Italy
A Amoroso, G Mazzola, M Berrino, et al.
Journal of Immunogenetics
|
June 1, 1990
HLA in juvenile dermatitis herpetiformis: clinical heterogeneity correlated with DNA and serological polymorphism
A Amoroso, G Mazzola, L Canale, et al.
Journal of Hepatology
|
August 8, 1998
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
A Amoroso, M Berrino, L Canale, et al.
Panminerva Medica
|
February 2, 2021
The core components of cardio-oncology rehabilitation
Elio Venturini, Susan Gilchrist, Elisabetta Corsi, et al.
Journal of Clinical Medicine
|
June 14, 2020
Oncology and Cardiac Rehabilitation: An Underrated Relationship
E Venturini, G Iannuzzo, A D'Andrea, et al.
Frontiers in Cardiovascular Medicine
|
February 7, 2024
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology
V Quagliariello, M Passariello, I Bisceglia, et al.
Frontiers in Cardiovascular Medicine
|
May 31, 2024
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
V Quagliariello, M L Canale, I Bisceglia, et al.
Cardio-Oncology (London, England)
|
September 2, 2025
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
A Greco, V Quagliariello, G Rizzo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Nephrology
|
January 1, 1990
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees
F Scolari, P Scaini, S Savoldi, et al.
The American Journal of Pathology
|
January 1, 1992
Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index
G R Merlo, T Venesio, A Bernardi, et al.
Gene Geography : a Computerized Bulletin on Human Gene Frequencies
|
April 1, 1991
HLA class II gene frequencies in Italy
A Amoroso, G Mazzola, M Berrino, et al.
Journal of Immunogenetics
|
June 1, 1990
HLA in juvenile dermatitis herpetiformis: clinical heterogeneity correlated with DNA and serological polymorphism
A Amoroso, G Mazzola, L Canale, et al.
Journal of Hepatology
|
August 8, 1998
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
A Amoroso, M Berrino, L Canale, et al.
Panminerva Medica
|
February 2, 2021
The core components of cardio-oncology rehabilitation
Elio Venturini, Susan Gilchrist, Elisabetta Corsi, et al.
Journal of Clinical Medicine
|
June 14, 2020
Oncology and Cardiac Rehabilitation: An Underrated Relationship
E Venturini, G Iannuzzo, A D'Andrea, et al.
Frontiers in Cardiovascular Medicine
|
February 7, 2024
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology
V Quagliariello, M Passariello, I Bisceglia, et al.
Frontiers in Cardiovascular Medicine
|
May 31, 2024
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
V Quagliariello, M L Canale, I Bisceglia, et al.
Cardio-Oncology (London, England)
|
September 2, 2025
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
A Greco, V Quagliariello, G Rizzo, et al.
Page
of 2